FREMONT, Calif.--(BUSINESS WIRE)--Confluent Medical Technologies (“Confluent Medical”), a global leader in medical device contract manufacturing, today completed the acquisition of Corpus Medical.
ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...
Hosted on MSN
Drug-eluting balloon may be as safe, effective as conventional stents for repeat percutaneous coronary interventions
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
The LMCA was engaged with an EBU 4 6 Fr guiding catheter through right radial approach.10000U of heparin was given. An Asahi soft guidewire was placed in Cx and balloon predilatation was made by 2x15 ...
For patients with restenosis in a sirolimus-eluting stent, a paclitaxel-eluting balloon is more effective at reducing the need for repeat revascularization than conventional balloon angioplasty, ...
Over $8 billion worth of coronary stents will be sold annually by 2025, according to a new research report by Global Market Insights, Inc. The increase over the years will be created by an increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results